A role for Hemopexin in oligodendrocyte differentiation and Myelin formation

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Morello, Noemi ^a   Bianchi, Federico Tommaso ^a   Marmiroli, Paola ^b   Tonoli, Elisabetta ^a   Menendez, Virginia Rodriguez ^b   Silengo, Lorenzo ^a   Cavaletti, Guido ^b   Vercelli, Alessandro ^a   Altruda, Fiorella ^a   Tolosano, Emanuela ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOPEXIN; MYELIN; MYELIN BASIC PROTEIN;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN TISSUE; CELL DENSITY; CELL MATURATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ELECTRON MICROSCOPY; IN VITRO STUDY; MOTOR CORTEX; MOTOR DYSFUNCTION; MOUSE; MOUSE MUTANT; MYELINATED NERVE; MYELINATION; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; ROTAROD TEST; SOMATOSENSORY CORTEX; 129 MOUSE; ANIMAL; BRAIN; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOTOR ACTIVITY; MYELIN SHEATH; PHYSIOLOGY; RAT; STEM CELL; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; WESTERN BLOTTING;

MUS;

ANIMALS; BLOTTING, WESTERN; BRAIN; CELL DIFFERENTIATION; CELLS, CULTURED; HEMOPEXIN; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, 129 STRAIN; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MOTOR ACTIVITY; MYELIN SHEATH; OLIGODENDROGLIA; RATS; STEM CELLS;

EID: 79957460022     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020173     Document Type: Article

References (49)

1. Bauer NG, ffrench-Constant C, (2009) Physical forces in myelination and repair: a question of balance? J Biol 8: 78.
2. Bauer NG, Richter-Landsberg C, Ffrench-Constant C, (2009) Role of the oligodendroglial cytoskeleton in differentiation and myelination. Glia 57: 1691-1705.
3. Baumann N, Pham-Dinh D, (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81: 871-927.
4. Dangata YY, Kaufman MH, (1997) Myelinogenesis in the optic nerve of (C57BL x CBA) F1 hybrid mice: a morphometric analysis. Eur J Morphol 35: 3-17.
5. Dyer CA, (2002) The structure and function of myelin: from inert membrane to perfusion pump. Neurochem Res 27: 1279-1292.
6. Hardy R, Reynolds R, (1991) Proliferation and differentiation potential of rat forebrain oligodendroglial progenitors both in vitro and in vivo. Development 111: 1061-1080.
7. Hardy R, Reynolds R, (1993) Neuron-oligodendroglial interactions during central nervous system development. J Neurosci Res 36: 121-126.
8. Skoff RP, (1976) Myelin deficit in the Jimpy mouse may be due to cellular abnormalities in astroglia. Nature 264: 560-562.
9. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, et al. (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33: 366-374.
10. Trapp BD, Nishiyama A, Cheng D, Macklin W, (1997) Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol 137: 459-468.
11. Tolosano E, Fagoonee S, Morello N, Vinchi F, Fiorito V, (2010) Heme scavenging and the other facets of hemopexin. Antioxid Redox Signal 12: 305-320.
12. Li RC, Saleem S, Zhen G, Cao W, Zhuang H, et al. (2009) Heme-hemopexin complex attenuates neuronal cell death and stroke damage. J Cereb Blood Flow Metab 29: 953-964.
13. Hunt RC, Hunt DM, Gaur N, Smith A, (1996) Hemopexin in the human retina: protection of the retina against heme-mediated toxicity. J Cell Physiol 168: 71-80.
14. Kapojos JJ, van den Berg A, van Goor H, te Loo MW, Poelstra K, et al. (2003) Production of hemopexin by TNF-alpha stimulated human mesangial cells. Kidney Int 63: 1681-1686.
15. Liem HH, Tavassoli M, Muller-Eberhard U, (1975) Cellular and subcellular localization of heme and hemopexin in the rabbit. Acta Haematol 53: 219-225.
16. Swerts JP, Soula C, Sagot Y, Guinaudy MJ, Guillemot JC, et al. (1992) Hemopexin is synthesized in peripheral nerves but not in central nervous system and accumulates after axotomy. J Biol Chem 267: 10596-10600.
17. Morello N, Tonoli E, Logrand F, Fiorito V, Fagoonee S, et al. (2009) Haemopexin affects iron distribution and ferritin expression in mouse brain. J Cell Mol Med 13: 4192-4204.
18. Tolosano E, Altruda F, (2002) Hemopexin: structure, function, and regulation. DNA Cell Biol 21: 297-306.
19. Gutteridge JM, Smith A, (1988) Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Biochem J 256: 861-865.
20. Vinchi F, Gastaldi S, Silengo L, Altruda F, Tolosano E, (2008) Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload. Am J Pathol 173: 289-299.
21. Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR, (2009) Oligodendrocytes and myelination: the role of iron. Glia 57: 467-478.
22. Tolosano E, Hirsch E, Patrucco E, Camaschella C, Navone R, et al. (1999) Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice. Blood 94: 3906-3914.
23. McCarthy KD, de Vellis J, (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890-902.
24. Zezula J, Casaccia-Bonnefil P, Ezhevsky SA, Osterhout DJ, Levine JM, et al. (2001) p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep 2: 27-34.
25. Lees MB, Samiullah M, Laursen RA, (1984) Structural analogies between myelin basic protein and proteolipid. Prog Clin Biol Res 146: 257-264.
26. Li Z, Zhang Y, Li D, Feng Y, (2000) Destabilization and mislocalization of myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNA-binding proteins. J Neurosci 20: 4944-4953.
27. Lu Z, Ku L, Chen Y, Feng Y, (2005) Developmental abnormalities of myelin basic protein expression in fyn knock-out brain reveal a role of Fyn in posttranscriptional regulation. J Biol Chem 280: 389-395.
28. Macklin WB, Gardinier MV, Obeso ZO, King KD, Wight PA, (1991) Mutations in the myelin proteolipid protein gene alter oligodendrocyte gene expression in jimpy and jimpymsd mice. J Neurochem 56: 163-171.
29. Younes-Rapozo V, Felgueiras LO, Viana NL, Fierro IM, Barja-Fidalgo C, et al. (2009) A role for the MAPK/ERK pathway in oligodendroglial differentiation in vitro: stage specific effects on cell branching. Int J Dev Neurosci 27: 757-768.
30. Larsen PH, DaSilva AG, Conant K, Yong VW, (2006) Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and-12 null mice. J Neurosci 26: 2207-2214.
31. Uhm JH, Dooley NP, Oh LY, Yong VW, (1998) Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia 22: 53-63.
32. Dedieu S, Langlois B, (2008) LRP-1: a new modulator of cytoskeleton dynamics and adhesive complex turnover in cancer cells. Cell Adh Migr 2: 77-80.
33. Hvidberg V, Maniecki MB, Jacobsen C, Hojrup P, Moller HJ, et al. (2005) Identification of the receptor scavenging hemopexin-heme complexes. Blood 106: 2572-2579.
34. Donahue JE, Flaherty SL, Johanson CE, Duncan JA 3rd, Silverberg GD, et al. (2006) RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol 112: 405-415.
35. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, et al. (2000) Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106: 1489-1499.
36. Zhang C, An J, Strickland DK, Yepes M, (2009) The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain. Am J Pathol 174: 586-594.
37. Piccard H, Van den Steen PE, Opdenakker G, (2007) Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins. J Leukoc Biol 81: 870-892.
38. Bakker WW, Borghuis T, Harmsen MC, van den Berg A, Kema IP, et al. (2005) Protease activity of plasma hemopexin. Kidney Int 68: 603-610.
39. Bakker WW, van Dael CM, Pierik LJ, van Wijk JA, Nauta J, et al. (2005) Altered activity of plasma hemopexin in patients with minimal change disease in relapse. Pediatr Nephrol 20: 1410-1415.
40. Cheung PK, Klok PA, Baller JF, Bakker WW, (2000) Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int 57: 1512-1520.
41. Spiller F, Costa C, Souto FO, Vinchi F, Mestriner FL, et al. (2011) Inhibition of neutrophil migration by hemopexin leads to increased mortality due to sepsis in mice. Am J Respir Crit Care Med 183: 922-931.
42. Chen L, Zhang X, Chen-Roetling J, Regan RF, (2010) Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice. J Neurosurg.
43. Roher AE, Maarouf CL, Sue LI, Hu Y, Wilson J, et al. (2009) Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease. Biomarkers 14: 493-501.
44. Dupree JL, Coetzee T, Suzuki K, Popko B, (1998) Myelin abnormalities in mice deficient in galactocerebroside and sulfatide. J Neurocytol 27: 649-659.
45. Ferreira AA, Nazario JC, Pereira MJ, Azevedo NL, Barradas PC, (2004) Effects of experimental hypothyroidism on myelin sheath structural organization. J Neurocytol 33: 225-231.
46. Zhu Q, Couillard-Despres S, Julien JP, (1997) Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp Neurol 148: 299-316.
47. Camborieux L, Bertrand N, Swerts JP, (1998) Changes in expression and localization of hemopexin and its transcripts in injured nervous system: a comparison of central and peripheral tissues. Neuroscience 82: 1039-1052.
48. Madore N, Camborieux L, Bertrand N, Swerts JP, (1999) Regulation of hemopexin synthesis in degenerating and regenerating rat sciatic nerve. J Neurochem 72: 708-715.
49. Madore N, Sagot Y, Guinaudy MJ, Cochard P, Swerts JP, (1994) Long-lasting accumulation of hemopexin in permanently transected peripheral nerves and its down-regulation during regeneration. J Neurosci Res 39: 186-194.